Published in Clin Exp Pharmacol Physiol on May 01, 1993
Interaction between bedding and sleeping position in the sudden infant death syndrome: a population based case-control study. BMJ (1990) 7.42
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96
Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature (1994) 4.78
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Straight talking: an investigation of the attitudes and practice of psychoanalysts and psychotherapists in relation to gays and lesbians. Br J Psychiatry (2001) 3.44
"Clusters" of anophthalmia in Britain. BMJ (1993) 3.04
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet (1999) 2.97
Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Chest (1998) 2.53
Food Poisoning Due to Toxic Substances Formed by Strains of the Cloacae-Aerogenes Group. Am J Public Health Nations Health (1932) 2.34
Streptococcal infection, Tourette syndrome, and OCD: is there a connection? Neurology (2009) 2.33
The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. Clin Infect Dis (1998) 2.31
Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg (1997) 2.23
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. Cochrane Database Syst Rev (2001) 2.08
NOTES ON THE CULTIVATION OF TREPONEMA PALLIDUM. J Exp Med (1915) 2.07
Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut (2009) 2.01
Approval of Laboratories for Surgical Pathology in New York State. Am J Public Health Nations Health (1934) 1.87
THE USE OF GLYCEROL AS A PRESERVATIVE FOR MILK SPECIMENS TO BE EXAMINED FOR HEMOLYTIC STREPTOCOCCI. Am J Public Health Nations Health (1933) 1.83
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation (1987) 1.78
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am J Cardiol (1997) 1.77
Reduced bone mass in daughters of women with osteoporosis. N Engl J Med (1989) 1.70
Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut (2002) 1.66
Postoperative pain control after lumbar spine fusion. Patient-controlled analgesia versus continuous epidural analgesia. Spine (Phila Pa 1976) (1997) 1.65
Changes in tidal volume, frequency, and ventilation induced by their measurement. J Appl Physiol (1972) 1.64
Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J Biol Chem (1999) 1.62
The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen (2005) 1.61
Psychological problems associated with diagnosis and treatment of lymphomas. I: Retrospective study. Br Med J (Clin Res Ed) (1987) 1.60
Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes (1991) 1.58
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat. Diabetologia (1989) 1.57
SIDS: risk reduction measures. Early Hum Dev (1994) 1.55
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia (2003) 1.55
The arterial-alveolar oxygen tension ratio. An index of gas exchange applicable to varying inspired oxygen concentrations. Am Rev Respir Dis (1974) 1.55
Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukoc Biol (1995) 1.54
In vivo gene electroinjection and expression in rat liver. FEBS Lett (1996) 1.53
Vascular muscle cell depolarization and activation in renal arteries on elevation of transmural pressure. Am J Physiol (1987) 1.48
Medical aspects of fitness to drive. What do public hospital doctors know and think? Intern Med J (2007) 1.47
Angiogenic factor from synovial fluid resembling that from tumours. Lancet (1980) 1.46
The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia (1995) 1.46
Rapid aneuploidy screening with fluorescence in-situ hybridisation: is it a sufficiently robust stand-alone test for prenatal diagnosis? Hong Kong Med J (2010) 1.43
Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia (2006) 1.42
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther (2003) 1.41
Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer. Curr Oncol (2010) 1.41
False-low carbon monoxide diffusing capacity measurement after general anesthesia. Chest (1996) 1.40
Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes (1994) 1.40
Treatment of diencephalic syndrome with chemotherapy: growth, tumor response, and long term control. Cancer (1998) 1.39
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes. Med J Aust (2001) 1.39
Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. J Wound Care (2010) 1.39
Microalbuminuria in diabetes. Med J Aust (1994) 1.38
Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats. Kidney Int (1998) 1.36
Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies. Intern Med J (2002) 1.35
Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology (2002) 1.35
Human Curvularia infections. Report of five cases and review of the literature. Diagn Microbiol Infect Dis (1987) 1.34
Tumour angiogenesis factor (TAF) and its neutralisation by a xenogeneic antiserum. Int J Cancer (1979) 1.34
Errors in blood transfusion in Britain: survey of hospital haematology departments. BMJ (1994) 1.29
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
ACTH precursors characterize the ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1994) 1.27
The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants. J Cell Biol (1985) 1.23
A comparison of guanacline with methyldopa in the treatment of hypertension. Med J Aust (1968) 1.21
An angiogenic factor isolated from tumours: a potent low-molecular-weight compound. Br J Cancer (1979) 1.21
Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs (2000) 1.19
Chemical synthesis, cloning and expression in mammalian cells of a gene coding for human tissue-type plasminogen activator. Gene (1988) 1.16
The fine structure of melanogenesis in coat color mutants of the mouse. J Ultrastruct Res (1973) 1.16
Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases. CMAJ (1992) 1.15
Measuring the wellbeing of family caregivers using the time trade-off technique. J Clin Epidemiol (1988) 1.14
Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther (2000) 1.14
Comparison of alprazolam plasma levels in normal Asian and Caucasian male volunteers. Psychopharmacology (Berl) (1988) 1.13
Methyldopa and haemolytic anaemia. Med J Aust (1967) 1.13
Metalloproteinase inhibitors from bovine cartilage and body fluids. Eur J Biochem (1984) 1.13
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. J Clin Invest (1997) 1.12
Agglutination in the Diagnosis of Enteric Disease. Am J Public Health Nations Health (1933) 1.12
Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG (2005) 1.11
Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect (2001) 1.10
Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology (2000) 1.10
Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes (2000) 1.09
Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin. J Cell Sci (1994) 1.09
Can pooled red cells be used for antibody screening of patients' specimens? Transfus Med (1996) 1.08
The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabet Med (2007) 1.08
Effects of aerobic exercise, resistance exercise or both, on patient-reported health status and well-being in type 2 diabetes mellitus: a randomised trial. Diabetologia (2009) 1.07
Grip strength, mental performance and nutritional status as indicators of mortality risk among female geriatric patients. Age Ageing (1986) 1.07
p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int J Oncol (1999) 1.07
Effect of thyroid status on ouabain binding to the human lymphocyte. J Clin Endocrinol Metab (1982) 1.06
Jaw wiring in treatment of obesity. Lancet (1977) 1.06
Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum Gene Ther (2000) 1.06
A low-molecular-weight angiogenic factor in cat retina. Br J Ophthalmol (1982) 1.05
Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res (1979) 1.05
Blood use for surgical patients: a study of Scottish hospital transfusion practices. J R Coll Surg Edinb (1995) 1.04
Infections of central nervous system shunts. Med Clin North Am (1985) 1.03
Stimulation by a low-molecular-weight angiogenic factor of capillary endothelial cells in culture. Br J Cancer (1980) 1.03
A research note on diagnosed mental illness and social class. Am Sociol Rev (1966) 1.03
Asynchronous breathing movements in patients with chronic obstructive pulmonary disease. Chest (1975) 1.03
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. Diabetologia (2000) 1.03
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes (2000) 1.03
Effect of ventilation on oxygen transfer during early exercise. J Appl Physiol (1966) 1.02
Evidence that B. Alkalescens (Andrewes) May Be a Variant of B. Typhosus Preliminary Report. Am J Public Health Nations Health (1934) 1.02
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. Mol Cell Endocrinol (2001) 1.02
Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther (2000) 1.02
In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity. Melanoma Res (2000) 1.02
Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol (1997) 1.01